What Matters Now
CME
Real-World Decisions in R/R B-Cell Lymphoma
0:00 / 0:00
Joshua Brody, M.D., Mount Sinai
Manik Uppal, M.D., Mount Sinai
90% of Peers Changed Their Practice After this Clinical Scenario
CME
Quickly manage potential CRS/ICANS amid competing priorities of time-sensitive intervention and differential diagnosis in non-academic settings.
What Matters Now
CME
0:00 / 0:00
Real-World Decisions in R/R B-Cell Lymphoma
Joshua Brody, M.D., Mount Sinai
Manik Uppal, M.D., Mount Sinai
Corresponding Scenario
Fever and Neurologic Symptoms 48 Hours After Bispecific Therapy
See experiences from 171 peers
Quickly manage potential CRS/ICANS amid competing priorities of time-sensitive intervention and differential diagnosis in non-academic settings.
How clinicians responded after this Clinical Scenario
67
%
begin unsure how to apply evidence
90
%
will implement a practice change
NEW!
Sharpen your clinical judgment for real-world care.
Discover how experts and peers reason
See where small differences in reasoning change safety, feasibility, and escalation decisions.
Reflect on your decision logic
Practice the thinking you used and spot gaps in judgment.
Calibrate your clinical reasoning
Side-by-side, reasoning patterns from peers and experts and how others de-risk their decisions.
Preview
Example: How Your Clinical Reasoning Compares with Peers
This table shows a representative example. Your actual peer comparison is generated after scenario completion.
CME Information
Program title: Evidence and Insight for Real-World Care in R/R B-cell Lymphomas
Jointly provided by Postgraduate Institute for Medicine and StitchedHealth, Inc.
Release date: March 17, 2026
Expiration date: March 17, 2027
Estimated time to complete activity: 15 min to 2 hours hours
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Target Audience
This activity is intended for hematology and medical oncology physicians, nurse practitioners, and physician assistants involved in the care of patients with relapsed or refractory B-cell lymphomas.
Get Started
Ready to refine your clinical judgment for everyday practice?
In a short (10 min) interactive scenario, explore how experts and peers reason through uncertainty and apply evidence in real-world care.
90% practice change rate among peers